4//SEC Filing
Jones Ryan Alexander 4
Accession 0000950170-24-065983
CIK 0001994702other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:33 PM ET
Size
10.5 KB
Accession
0000950170-24-065983
Insider Transaction Report
Form 4
Jones Ryan Alexander
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-28$0.73/sh+10,870$7,935→ 36,804 total - Exercise/Conversion
Common Stock
2024-05-28$0.73/sh+7,146$5,217→ 43,950 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-28−10,870→ 0 totalExercise: $0.73→ Common Stock (10,870 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-28−7,146→ 2,192 totalExercise: $0.73→ Common Stock (7,146 underlying)
Footnotes (2)
- [F1]25% of the original number of shares subject to the option vested on April 15, 2021, and 1/48th of the original number of shares subject to the option vested in monthly installments thereafter.
- [F2]25% of the original number of shares subject to the option vested on January 1, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0002007219
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:33 PM ET
- Size
- 10.5 KB